Allogeneic bone marrow transplantation.

From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates. With further exploration into its efficacy, allogeneic BMT will bring new challenges and opportunities for patients, families, and health care providers.

[1]  B. Afessa,et al.  Outcome of recipients of bone marrow transplants who require intensive-care unit support. , 1992, Mayo Clinic proceedings.

[2]  S. Forman,et al.  Allogeneic bone marrow transplantation for acute leukemia. , 1990, JAMA.

[3]  R. Parkman,et al.  Bone marrow transplantation for the treatment of immune deficiency states. , 1990, Bone marrow transplantation.

[4]  A. Ribas,et al.  What is the role of recombinant colony stimulating factors in bone marrow transplantation? , 1990, Bone marrow transplantation.

[5]  E. Thomas,et al.  Indications for marrow transplantation in chronic myelogenous leukemia. , 1989, Blood.

[6]  C. Parchem,et al.  Ambulatory care of the bone marrow transplant patient. , 1988, Seminars in oncology nursing.

[7]  L. R. Hill,et al.  ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA DURING FIRST COMPLETE REMISSION , 1987, Transplantation.

[8]  M. Horowitz,et al.  Current status of allogeneic bone marrow transplantation. , 1990, Clinical transplants.

[10]  R. Gale,et al.  T cell depletion in bone marrow transplantation for leukemia: current results and future directions. , 1988, Bone marrow transplantation.

[11]  A. Rimm,et al.  Increasing Utilization of Allogeneic Bone Marrow Transplantation , 1992, Annals of Internal Medicine.

[12]  A. Rimm,et al.  Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.

[13]  N. Chao,et al.  Bone marrow transplantation. Part I--Allogeneic. , 1989, The Western journal of medicine.

[14]  B. Ferrell,et al.  The meaning of quality of life for bone marrow transplant survivors Part 1. The impact of bone marrow transplant on quality of life , 1992, Cancer nursing.

[15]  W. Woods,et al.  Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children , 1988, British journal of haematology.

[16]  B. Ballard,et al.  Acute complications after bone marrow transplantation. , 1988, Seminars in oncology nursing.

[17]  G. Lucarelli,et al.  Bone marrow transplantation in patients with thalassemia. , 1990, The New England journal of medicine.

[18]  G. Reaman,et al.  Acute lymphoblastic leukemia in childhood. , 1985, Pediatric clinics of North America.

[19]  Jerry R. Hobbs,et al.  REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATION , 1981, The Lancet.

[20]  L. Lum Immune recovery after bone marrow transplantation. , 1990, Hematology/oncology clinics of North America.

[21]  S. Freedman,et al.  An overview of bone marrow transplantation. , 1988, Seminars in oncology nursing.

[22]  A. Nademanee,et al.  Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission , 1991 .

[23]  J. Klein,et al.  Bone marrow transplantation for Fanconi anemia. , 1995, Blood.

[24]  R. Gale,et al.  Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. , 1987, Seminars in hematology.

[25]  N. Wedel,et al.  Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gram‐negative sepsis , 1992, Critical care medicine.

[26]  J. Reiffers,et al.  Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial , 1989, British journal of haematology.

[27]  J. Rossi,et al.  Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. , 1990, Bone marrow transplantation.

[28]  Eliane Gluckman,et al.  Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. , 1989 .

[29]  M. Durbin Bone marrow transplantation: economic, ethical, and social issues. , 1988, Pediatrics.

[30]  M. Horowitz,et al.  Current status of bone marrow transplantation. , 1989, Clinical transplants.

[31]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.

[32]  X. Troussard,et al.  Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric study. , 1990, Haematology and blood transfusion.

[33]  R. Storb,et al.  Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.

[34]  C. Moravec,et al.  The critically ill bone marrow transplant patient. , 1988, Seminars in oncology nursing.

[35]  P. Rieker,et al.  Pediatric bone marrow transplantation: psychosocial issues for parents after a child's hospitalization , 1995 .

[36]  S. Teitelbaum,et al.  Successful bone-marrow transplantation for infantile malignant osteopetrosis. , 1980, The New England journal of medicine.

[37]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.

[38]  E. Conde,et al.  Complete recovery of hemopoiesis following bone marrow transplant in a patient with unresponsive congenital hypoplastic anemia (Blackfan-Diamond syndrome). , 1984, Blood.

[39]  J. Laver,et al.  Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. , 1991, The Journal of pediatrics.

[40]  R. Gale,et al.  Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. , 1991, Bone marrow transplantation.

[41]  C. Coltman,et al.  Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Y. Beyth,et al.  ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.

[43]  J. Nims,et al.  Late complications of bone marrow transplant recipients: nursing care issues. , 1988, Seminars in oncology nursing.

[44]  Oligonucleotide-based therapeutics , 1991, Nature.

[45]  F. Appelbaum,et al.  Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up , 1988 .

[46]  R. Gale Potential utilization of a national HLA-typed donor pool for bone marrow transplantation. , 1986, Transplantation.

[47]  H. Braine,et al.  Specialized cell component therapy. , 1990, Seminars in oncology nursing.

[48]  J. Armitage,et al.  Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. , 1991, American Journal of Medicine.

[49]  D. Jabs,et al.  Thalidomide for the treatment of chronic graft-versus-host disease. , 1992, The New England journal of medicine.

[50]  E. Herrick,et al.  Recipients of bone marrow transplants: making a smooth transition to an ambulatory care setting. , 1990, Oncology nursing forum.

[51]  A. Yeager Pediatric bone marrow transplantation. , 1991, Pediatrics in review.

[52]  M. Farrall,et al.  Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. , 1989, Bone marrow transplantation.

[53]  K. Sullivan,et al.  Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. , 1987, Progress in clinical and biological research.

[54]  G. Dini,et al.  Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission. , 1986, Bone marrow transplantation.

[55]  R. Storb,et al.  Marrow transplantation from unrelated HLA-matched volunteer donors. , 1989, Transplantation proceedings.